The phenotypic and genetic features of arrhythmogenic cardiomyopathy in the pediatric population

The present study aimed to describe the phenotypic features and genetic spectrum of arrhythmogenic cardiomyopathy (ACM) presented in childhood and test the validity of different diagnostic approaches using Task Force Criteria 2010 (TFC) and recently proposed Padua criteria.Thirteen patients (mean age at diagnosis 13.6 ± 3.7 years) were enrolled using “definite” or “borderline” diagnostic criteria of ACM according to the TFC 2010 and the Padua criteria in patients <18 years old. Clinical data, including family history, 12-lead electrocardiogram (ECG), signal-averaged ECG, 24-h Holter monitoring, imaging techniques, genetic testing, and other relevant information, were collected.All patients were classified into three variants: ACM of right ventricle (ACM-RV; n = 6, 46.1%), biventricular ACM (ACM-BV; n = 3, 23.1%), and ACM of left ventricle (ACM-LV; n = 4, 30.8%). The most common symptoms at presentations were syncope (n = 6; 46.1%) and palpitations (n = 5; 38.5%). All patients had more than 500 premature ventricular contractions per day. Ventricular tachycardia was reported in 10 patients (76.9%), and right ventricular dilatation was registered in 8 patients (61.5%). An implantable cardiac defibrillator was implanted in 61.5% of cases, and three patients with biventricular involvement underwent heart transplantation. Desmosomal mutations were identified in 8 children (53.8%), including four patients with PKP2 variants, two with DSP variants, one with DSG2 variant, and one with JUP. Four patients carried compound heterozygous variants in desmosomal genes associated with left ventricular involvement.Arrhythmias and structural heart disease, such as chamber dilatation, should raise suspicion of different ACM phenotypes. Diagnosis of ACM might be difficult in pediatric patients, especially for ACM-LV and ACM-BV forms. Our study confirmed that using “Padua criteria” in combination with genetic testing improves the diagnostic accuracy of ACM in children.

[1]  M. Giacca.  Gene editing for cardiomyopathy takes a step forward. , 2022, Cardiovascular research.

[2]  T. Sejersen,et al.  Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood , 2022, Orphanet Journal of Rare Diseases.

[3]  C. James,et al.  Genotype–phenotype Correlates in Arrhythmogenic Cardiomyopathies , 2022, Current Cardiology Reports.

[4]  C. Basso,et al.  Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator , 2022, European heart journal.

[5]  Vassilios J. Bezzerides,et al.  Population Prevalence of Premature Truncating Variants in Plakophilin-2 and Association With Arrhythmogenic Right Ventricular Cardiomyopathy: A UK Biobank Analysis , 2022, Circulation. Genomic and precision medicine.

[6]  F. Drago,et al.  Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? , 2022, Journal of cardiovascular development and disease.

[7]  D. Khraiche,et al.  Clinical Presentation and Heart Failure in Children With Arrhythmogenic Cardiomyopathy. , 2022, Circulation. Arrhythmia and electrophysiology.

[8]  A. Amodeo,et al.  Arrhythmogenic cardiomyopathy in children according to "Padua criteria": Single pediatric center experience. , 2022, International journal of cardiology.

[9]  D. Corrado,et al.  Arrhythmogenic Cardiomyopathy. , 2021, Circulation research.

[10]  K. Klingel,et al.  Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset , 2021, International journal of molecular sciences.

[11]  T. Rusak,et al.  A paradigm shift in the concept of arrhythmogenic cardiomyopathy: expanding the clinical and genetic spectrum, new diagnostic criteria for left ventricular phenotypes , 2020, Russian Journal of Cardiology.

[12]  T. Sejersen,et al.  Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants , 2020, Genes.

[13]  A. Mazzanti,et al.  Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.

[14]  D. Corrado,et al.  Natural History of Arrhythmogenic Cardiomyopathy , 2020, Journal of clinical medicine.

[15]  M. Link,et al.  2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. , 2019, Heart rhythm.

[16]  C. Perret,et al.  FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype‐phenotype correlations , 2019, Clinical genetics.

[17]  Vassilios J. Bezzerides,et al.  Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. , 2019, Journal of the American College of Cardiology.

[18]  J. Rosenfeld,et al.  Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy‐associated genes among children undergoing exome sequencing reflect healthy population variation , 2019, Molecular genetics & genomic medicine.

[19]  Paul M. K. Gordon,et al.  Characterization of a Unique Form of Arrhythmic Cardiomyopathy Caused by Recessive Mutation in LEMD2 , 2019, JACC. Basic to translational science.

[20]  Matthew S. Lebo,et al.  Electronic Health Record Phenotype in Subjects with Genetic Variants Associated with Arrhythmogenic Right Ventricular Cardiomyopathy: A Study in 30,716 Subjects with Exome Sequencing , 2017, Genetics in Medicine.

[21]  S. Yoo,et al.  Left Ventricular Function in Children and Adolescents With Arrhythmogenic Right Ventricular Cardiomyopathy. , 2017, The American journal of cardiology.

[22]  Stefania Rizzo,et al.  Arrhythmogenic cardiomyopathy , 2016, Orphanet Journal of Rare Diseases.

[23]  Phillip C. Quigley,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria , 2016, Pediatric Cardiology.

[24]  R. Hauer,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease. , 2015, JACC. Clinical electrophysiology.

[25]  B. McCrindle,et al.  Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents. , 2015, Journal of the American College of Cardiology.

[26]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[27]  T. Lüscher,et al.  Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia , 2015, BMC Cardiovascular Disorders.

[28]  W. Ravekes,et al.  Reference values and calculation of z-scores of echocardiographic measurements of the normal pediatric right ventricle. , 2014, The American journal of cardiology.

[29]  P. Kowey,et al.  The Electrocardiographic Manifestations of Arrhythmogenic Right Ventricular Dysplasia , 2014, Current cardiology reviews.

[30]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[31]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.

[32]  M. Vorgerd,et al.  De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. , 2010, Human molecular genetics.

[33]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[34]  David F Dickinson,et al.  The normal ECG in childhood and adolescence , 2005, Heart.